Michael Rosove, MD

Michael Rosove, MD

Clinical Professor, Department of Medicine, Hematology/Oncology
Physician, Department of Medicine, Hematology/Oncology




Cancer/Medical Oncology, Hematology, Internal Medicine

Institutional Affiliation

Ronald Reagan UCLA Medical Center



Medicine, Hematology/Oncology, Columbia Presbyterian Medical Center, 1977 - 1978
Hematology/Oncology, UCLA School of Medicine, 1976 - 1979


Internal Medicine, UCLA School of Medicine, 1973 - 1974


MD, UCLA School of Medicine, 1973


Internal Medicine, UCLA School of Medicine, 1974 - 1976

Board Certifications

Hematology, American Board of Internal Medicine, 1982
Medical Oncology, American Board of Internal Medicine, 1981
Internal Medicine, American Board of Internal Medicine, 1976

Contact Information


(310) 206-6909 - Hematology/Oncology Information and Patient Appointments
(888) 662-8252 - Community Oncology Practice Information and Patient Appointments
(310) 794-4955 - Community Oncology Practice Information

Clinical Interests

Hemostasis and Thrombosis, General Hematology, Myeloproliferative and Myelodysplastic Disorders, Hematologic Malignancies, Head and Neck Cancer, Lung Cancer, General Medical Oncology

Scientific Interests

Dr. Michael Rosove's research focuses on disorders of hemostasis and thrombosis, and he also has an interest in hematological malignancies and hepatocellular carcinoma.

Highlighted Publications

Marder VJ, Rosove MH, Minning DM. Foundation and sites of action of antithrombotic agents. Best Pract Res Clin Haematol. 2004 Mar;17(1):3-22.

Rosove MH. Platelet glycoprotein IIb/IIIa inhibitors. Best Pract Res Clin Haematol. 2004 Mar;17(1):65-76.

Salomon O, Zivelin A, Livnat T, Dardik R, Loewenthal R, Avishai O, Steinberg DM, Rosove MH, O'Connell N, Lee CA, Seligsohn U. Prevalence, causes, and characterization of factor XI inhibitors in patients with inherited factor XI deficiency. Blood. 2003 Jun 15;101(12):4783-8. Epub 2003 Feb 13.